Medicare Enrolled

Dr. Carl Regillo, MD

Ophthalmology · Plymouth Meeting, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
4060 BUTLER PIKE, Plymouth Meeting, PA 19462
8003316634
In practice since 2006 (20 years)
NPI: 1740248038 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Regillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Regillo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Regillo

Dr. Carl Regillo is an ophthalmology specialist in Plymouth Meeting, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Regillo performed 54,345 Medicare services across 6,402 unique beneficiaries.

Between the years covered by Open Payments, Dr. Regillo received a total of $734,262 from 41 pharmaceutical and/or device companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Regillo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in PA $734,262 industry payments

Medicare Practice Summary

Medicare Utilization ↗
54,345
Medicare services
Top 1% in PA for ophthalmology
6,402
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,717 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
24,300 $29 $73
Injection, ranibizumab, 0.1 mg 5,930 $188 $900
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
5,565 $31 $145
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
4,888 $216 $800
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
3,664 $68 $195
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
3,656 $104 $482
Aflibercept eye injection (Eylea) 3,232 $689 $2,433
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
1,365 $120 $466
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
845 $95 $275
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
290 $125 $355
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
150 $80 $483
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
141 $19 $85
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
118 $1,751 $6,641
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
63 $40 $215
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
51 $31 $215
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
38 $927 $6,125
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $66 $235
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
17 $117 $330
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
14 $117 $435
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$734,262
Total received (2018-2024)
Avg $104,895/year across 7 years
Top 0% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
386
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$585,562 (79.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$143,004 (19.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,696 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$190,209
2023
$83,011
2022
$105,896
2021
$76,212
2020
$71,131
2019
$132,958
2018
$74,845

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EyePoint Pharmaceuticals US, Inc.
$117,237
Apellis Pharmaceuticals, Inc.
$33,407
Genentech USA, Inc.
$11,087
Boehringer Ingelheim International GmbH
$9,650
SANOFI US SERVICES INC.
$4,743
BioCryst Pharmaceuticals, Inc.
$4,200
F. Hoffmann-La Roche AG
$2,956
Astellas Pharma US Inc
$2,441
Novartis Pharma AG
$1,720
Merck Sharp & Dohme LLC
$1,688
Hexal AG
$538
Regeneron Healthcare Solutions, Inc.
$242
Regeneron Pharmaceuticals, Inc.
$134
Alimera Sciences, Inc.
$100
Coherus Biosciences Inc.
$68
Top 3 companies account for 85.0% of 2024 payments
All-time payments by company (2018-2024) ›
EyePoint Pharmaceuticals US, Inc.
$176,374
F. Hoffmann-La Roche AG
$111,985
Apellis Pharmaceuticals, Inc.
$72,205
Genentech, Inc.
$70,839
Genentech USA, Inc.
$61,445
Novartis Pharmaceuticals Corporation
$41,564
Shire North American Group Inc
$17,748
Astellas Pharma US Inc
$17,141
Merck Sharp & Dohme Corporation
$14,362
Boehringer Ingelheim International GmbH
$13,950
Bausch & Lomb Americas Inc.
$11,921
Janssen Global Services, LLC
$11,431
Ocular Therapeutix, Inc.
$9,348
Novartis Pharma AG
$9,245
NotalVision
$7,200
Coherus Biosciences Inc.
$7,113
Hoffmann-La Roche Limited
$7,065
Allergan Inc.
$6,627
Takeda Pharmaceuticals U.S.A., Inc.
$6,375
Regeneron Healthcare Solutions, Inc.
$5,995
Hexal AG
$5,913
Allergan, Inc.
$5,348
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,750
SANOFI US SERVICES INC.
$4,743
Vertex Pharmaceuticals Incorporated
$4,475
BioCryst Pharmaceuticals, Inc.
$4,200
Alcon Vision LLC
$3,915
Kala Pharmaceuticals, Inc.
$3,863
Carl Zeiss Meditec, Inc.
$2,995
Alcon Research LLC
$2,625
Roche Products Limited
$2,224
Oyster Point Pharma, Inc.
$2,142
Merck Sharp & Dohme LLC
$2,062
VERTEX PHARMACEUTICALS INCORPORATED
$1,115
Alcon Research Ltd
$985
ABBVIE INC.
$972
Teva Pharmaceuticals USA, Inc.
$900
Alexion Pharmaceuticals, Inc.
$812
Regeneron Pharmaceuticals, Inc.
$175
Alimera Sciences, Inc.
$100
Halozyme Inc
$14
Top 3 companies account for 49.1% of all-time payments
Associated products mentioned in payments ›
AJOVY · AcrySof IQ VIVITY · BEOVU · BROLUCIZUMAB · BUPARLISIB · Cimerli · Constellation · DEXTENZA · DEXYCU · EYLEA · EYLEA HD · EYP-1901 · ForeseeHome · Hylenex · ILEVRO · ILUVIEN · INVELTYS · Izervay · Lucentis · MK-8931 · Non-Covered Product · OZURDEX · RTH258A_BEOVU_OPHTHALMOLOGY · RTH258B_BEOVU_OPHTHALMOLOGY · SUSVIMO · Susvimo · Syfovre · TAKHZYRO · TYRVAYA · VABYSMO · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for ophthalmology in PA.

Looking for an ophthalmology specialist in Plymouth Meeting?
Compare ophthalmologists in the Plymouth Meeting area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
507
Per 100K population
58.9
County median income
$111,521
Nearest hospital
SUBURBAN COMMUNITY HOSPITAL
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Regillo is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with consulting-driven industry engagement in the top 0% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Regillo experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Regillo performed 24,300 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Regillo receive payments from pharmaceutical companies?
Yes. Dr. Regillo received a total of $734,262 from 41 companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Regillo's costs compare to other ophthalmologists in Plymouth Meeting?
Dr. Regillo's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Regillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →